Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4

Published:2024-04-12 Issue:5 Volume:21 Page:2415-2424
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Yang Tingting¹²,Shi Dai¹²^ORCID,Lin Qingyu¹²,Shen Hua³,Tan Hui¹²,Liu Yuxia³,Shi Hongcheng¹²,Cheng Dengfeng¹²^ORCID

Affiliation:

1. Shanghai Institute of Medical Imaging, Shanghai 200032, China

2. Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China

3. Department of Applied Chemistry, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Funder

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Shanghai Rising-Star Program

Clinical Research Project of Zhongshan Hospital

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.3c01221

Reference29 articles.

1. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine

2. Nuclear medicine in precision oncology: a foreword

3. CXCR4-targeted theranostics in oncology

4. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy

5. HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP